Protecting the Rights and Welfare of Human Research Participants - PowerPoint PPT Presentation

1 / 53
About This Presentation
Title:

Protecting the Rights and Welfare of Human Research Participants

Description:

Usually a broad dissemination of the results is planned (ie, publication, presentation, etc. ... changes to the protocol only with prospective review and ... – PowerPoint PPT presentation

Number of Views:92
Avg rating:3.0/5.0
Slides: 54
Provided by: rese183
Category:

less

Transcript and Presenter's Notes

Title: Protecting the Rights and Welfare of Human Research Participants


1
Protecting the Rights and Welfare of Human
Research Participants
NDSU Institutional Review Board Teri Grosz,
Director
2
FederalWide Assurance (FWA00002439)
  • The DHHS Office of Human Research Protections
    (OHRP) has approved NDSU to conduct research with
    human subjects.
  • Terms of the FWA state how NDSU will protect the
    rights and welfare of those who volunteer for
    research projects.
  • These procedures are detailed in the NDSU IRB
    Guidelines (www.ndsu.edu/irb ).

3
  • What is a human subject/participant?
  • When does a human subject become involved in
    research?
  • What ethical principles should be considered when
    conducting research involving human subjects?
  • What are NDSUs requirements when conducting
    human subjects research?

4
  • Human subject/participant
  • - a living individual about whom an
    investigator conducting research obtains either
    (1) data through intervention or interaction with
    the individual, or (2) private information (DHHS,
    45 CFR 46.102)
  • - an individual who becomes a participant in
    research, either as a recipient of a test article
    or as a control. May be a healthy human or a
    patient. (FDA, 21 CFR 50.3)

5
  • Intervention includes both physical procedures
    by which data are gathered, and manipulations of
    the subject or their environment
  • Interaction communication or interpersonal
    contact between investigator and subject
  • Private information
  • information about behavior that occurs in an
    environment in which one can reasonably expect no
    observation or recording is taking place
  • information provided for another purpose that one
    would expect not to be made public (ie, medical
    or other private records)

6
Research
  • A systematic investigation, research development,
    testing or evaluation designed to develop or
    contribute to generalizable knowledge (DHHS, 45
    CFR 46.102)
  • There is an intent to draw conclusions beyond the
    specific instances being studied, inform policy,
    or generalize findings
  • Usually a broad dissemination of the results is
    planned (ie, publication, presentation, etc.)

7
  • Research maybe conducted as part of a larger
    project with other objectives (ie, an educational
    initiative with assessment activities)
  • Research may be conducted as part of a dual-use
    project (ie, employer assigned duty and MS/PhD
    thesis NDSU research and outside entity project)

8
Are course assignments research?
  • Sometimes a class assignment will involve
    collection of data from human subjects (surveys,
    interviews) in research-like activities.
  • The same ethical principles should be used for
    conducting the activity, but NDSU IRB does not
    consider this project to be research if it will
    be used ONLY for fulfilling requirements of the
    course.
  • This project would be research if either the
    instructor or the student ALSO intends to broadly
    disseminate the results (ie, in a publication,
    presentation, dissertation, etc.)

9
  • All projects that fit the definition of
  • human subjects research must follow
  • Federal regulations and NDSU policies
  • to protect participants rights and
  • welfare.
  • These projects are not limited to clinical
    studies, or social and behavioral science fields.
  • May be conducted in any department or unit across
    campus, and in many different fields.

10
The rights and welfare of research participants
are protected by federal regulations and
institutional policies
  • Code of Federal Regulations, Title 45 Public
    Welfare, Part 46 Protection of Human Subjects
  • Code of Federal Regulations, Title 21 Food and
    Drugs, Part 50 Protection of Human Subjects
  • NDSU IRB Guidelines http//www.ndsu.nodak.edu/irb/
    forms/irb_guidelines.pdf

11
What ethical principles should be considered when
conducting research involving human participants?
  • The Belmont Report, 1979
  • http//www.hhs.gov/ohrp/humansubjects/guidance/bel
    mont.htm
  • Respect for persons
  • Beneficience
  • Justice

12
Respect for persons gtgtInformed Consent
  • Research participation is a voluntary choice.
  • Participation (or choosing not to participate)
    should not affect any other rights or benefits
    participants would be entitled to.
  • Subjects must receive adequate and understandable
    information about the research.

13
Recruitment of subjects should be done in an
environment free of any coersion (overt or subtle)
  • Dual relationships/dual roles
  • Instructor/student
  • Employer/employee
  • Physician/patient
  • Compensation offer an alternative (ie, for extra
    credit) equal in time/effort to research
    participation

14
Participants must be provided with the following
information in non-technical, lay language
  • Invitation to participate in a research study
  • Participation is voluntary, can quit anytime
  • Purpose of research, who is conducting it, how
    long it will take
  • Description of any potential risks/discomforts,
    benefits
  • Alternatives to participation, if any (ie, other
    ways to earn extra credit, etc)
  • Description of if/how the information they
    provide will be held confidential, how the data
    will be reported
  • Contact information for researchers, and IRB
    office

15
  • Consent shall be sought in an environment that
    minimizes the possibility of coercion or undue
    influence.
  • Research subjects cannot be made to waive their
    legal rights, or release the investigator,
    institution, or agency from liability for
    negligence.

16
Beneficence gtgt
  • An obligation to protect persons from harm
  • Maximize research benefits and minimize any
    possible harms

17
  • Possible harms resulting from research
    participation
  • Physical
  • Psychological (raises unaddressed issues)
  • Sociological (embarrassment, invasion of privacy)
  • Economic (loss of job)
  • Legal (admission of crimes)
  • Loss of privacy

Subjects may be harmed if confidentiality of
identifiable research data is breached and
becomes known to others outside the research
project.
18
(No Transcript)
19
Psychological Harms
  • Negative perception of self
  • Emotional suffering (anxiety, shame)
  • Aberrations of thought or behavior
  • Anger, guilt
  • Distress, fear (upon learning of a diagnosis)

20
Social Harms
  • Negative effects on interactions or relationships
    with others
  • Social stigmatization

21
Economic Harms
  • Imposition of financial costs
  • Loss of health insurance
  • Loss of employment

22
Possible harms
  • Likelihood (probability)
  • Severity (magnitude)
  • Low probability/trivial harm
  • High probability/trivial harm
  • Low probability/severe harm
  • High probability/severe harm
  • gtgtDesign study to reduce the likelihood and
    reduce the magnitude of harms

23
Minimize risk of harms to subjects
  • Researchers are qualified to conduct the study,
    and handle any immediate adverse event
  • Collect data in an anonymous fashion (no
    information that could potentially identify a
    subject is collected at any time in the study)
  • Have robust confidentiality procedures in place
    (especially for sensitive data)
  • Participants will be provided with counseling
    referrals (if applicable)

24
Maintain confidentiality of sensitive data
  • Use a coded or numbered list that is kept
    separate from raw data
  • Limit access to raw data (physical, and
    electronic security procedures)
  • Remove identifiers at earliest opportunity

25
  • Maximize potential benefits of research
  • Design study to yield useful and valid results
    that will contribute to generalizable knowledge
    in the field.
  • Provide participants with feedback about analysis
    of their individual information (if possible).
  • Provide participants with an increased knowledge
    of a particular topic, or an increased awareness
    of their traits, habits, or behaviors.
  • Provide subjects with an understanding of
    research participation and how research is
    conducted.

26
Justice gtgt Fair distribution of research burdens
and benefits
  • In the past, some high-risk research projects
    singled out only vulnerable, dis-enfranchised
    groups
  • Current regulations require extra protections
    when vulnerable groups are involved in research

27
Vulnerable populations
  • Children
  • Prisoners
  • Pregnant women
  • Terminally ill, mentally incapacitated,
    elderly/aged, economically or educationally
    disadvantaged persons

28
Research involving children
  • In ND, under 18 yrs of age
  • Requires parental consent, youth assent
  • A childs objections should override parental
    consent
  • Includes some college freshman
  • If a college-aged group, some studies choose to
    limit participation to those 18 and older

29
Research involving prisoners
  • Now very restricted after reports of abuse of
    prisoners in dermatological research
  • Prison is a limited choice environment
  • Prisoner anyone involuntarily confined or
    detained in a penal institution
  • May only be involved with research that studies
    the prison environment or criminal behavior

30
What are NDSUs requirements for conducting human
subjects research?
  • Detailed in the IRB Guidelines based on federal
    regulations, FWA terms and NDSU policy.
  • Obtain prospective review and approval of the
    project from the IRB.
  • Conduct project according to approved protocol,
    following Belmont principles.
  • Report to the IRB any adverse events, problems,
    or other events that place participants at risk
    of harm.
  • Make changes to the protocol only with
    prospective review and approval of the IRB.
  • Submit continuing review/completion reports to
    the IRB (if applicable) on an annual basis.

31
NDSU IRB Members, 2004-2005
  • Bob Sylvester, Chair, College of Pharmacy
  • Joe Mike Jones, Vice Chair, College of Business
  • Jim Council, College of Science Math
  • Joel Hektner, College of Human Development
    Education
  • Leanna Bouffard, College of Arts, Humanities
    Social Sciences
  • Julie Garden-Robinson, Extension Service, Food
    Nutrition
  • Paul Ode, College of Agriculture
  • Dennis Cooley, ethicist, College of Arts,
    Humanities Social Sci.
  • Rhonda Magel, Dept. of Statistics, College of
    Science Math
  • V. B. Rao, College of Engineering
  • Don Matthees, MD, Innovis Hospital
  • Pastor Julie Tweit, Boulger Funeral Home

32
How to obtain IRB approval of your project
  • Prepare a protocol to submit to the IRB (Forms
    page)
  • Project will be reviewed according to IRB
    Guidelines
  • You will be notified of approval of the project,
    or requested to provide additional information,
    and/or revisions
  • You may begin collecting data

33
IRB Protocol includes
  • Protocol form (example on website)
  • Informed consent document (oral script, handout,
    cover letter, or signed)
  • List of survey/interview questions (if
    applicable)
  • Permission letter from cooperating group (if
    applicable)
  • Recruitment ad (copy, or oral script, if
    applicable)

34
Protocol review procedure varies with risk level
of the project
  • Exempt categories of research little or no
    risk of possible harm to subjects, 6 categories
  • Expedited review some risk of harm is
    possible, 9 categories
  • Full Board review greater risk of harm,
    and/or involves a vulnerable participant group
  • Protocol form provides guidance for what level of
    review is required for the research project.

35
Obtain prospective IRB approval for any changes
made to the approved protocol
  • Additional investigators
  • Additional study procedures
  • A change in the participant group
  • A change in recruitment procedures
  • Additional information collected from subjects
  • Other changes

36
Continuing Review Requirements
  • Applies to only expedited and full-board projects
  • IRB must review at least once/year
  • of participants enrolled/completed/to be
    recruited
  • Adverse events, problems, withdrawals
  • Significant new findings, summary of results

37
Reporting Requirements(Researcher gtgtgt IRB)
  • Research-related injuries
  • Adverse reactions or events
  • Problems/complaints from participants
  • Breach of confidentiality of sensitive data
  • Other unanticipated problems involving risks to
    subjects or others

38
Reporting requirements(IRB gtgtgtOHRP,
institutional officials, funding agency, other
entities)
  • Suspension or termination of a study
  • Unanticipated event involving risks to subjects
    or others
  • Serious or continuing noncompliance with the
    federal regulations and/or IRB directives

39
Different Types of Research involving Human
Participants
40
  • Research on regular and special education
    instructional strategies, effectiveness of
    instructional techniques, curricula, or classroom
    management methods
  • Normal educational practice, normal educational
    setting
  • Parental consent, child assent, if minors
    involved

41
Research involving the use of educational tests,
surveys, interviews, focus groups, oral histories
  • Identifiers ? Anonymous?
  • Collection of sensitive information?
  • Recruitment procedures
  • Compensation offered?
  • Alternatives?
  • Maintaining confidentiality

42
Observation of public behavior
  • Interaction with participants ?
  • Collection of identifiers ?
  • Nature of the data collected
  • May qualify for a waiver of informed consent

43
Research involving medical records, academic
records, other documents, or datasets
  • Publicly available information?
  • Pre-existing vs. future records ?
  • Already being collected for another purpose
  • Legitimate access ? Other regulations may also
    apply (HIPAA, FERPA)
  • May be a concern with invasion of privacy
  • Identifiers or de-identified ?
  • May qualify for a waiver of informed consent

44
Research involving human biological tissues,
specimens
  • Commercially available?
  • Pre-existing, or future collections?
  • Collected for research, or other purposes?
  • Identifiers included? Medical info included?
  • Training in Bloodborne Pathogens, IBC protocol

45
  • Taste and food quality evaluations, consumer
    acceptance studies
  • Wholesome foods, no additives
  • Safe levels of ag chemicals, contaminants

46
Exercise studies, muscular strength
testing, flexibility testing
  • Subject inclusion/exclusion criteria
  • Address how to deal with potential injuries,
    health problems related to the study medical
    treatment, payment plan
  • Inform IRB of injuries, adverse events, etc.,

47
Collection of data from voice, video, digital,
or image recordings
  • Identifiers collected?
  • Sensitive information? Confidentiality?
  • Disposition of audio/video tapes length of
    storage, access, destroyed once information has
    been obtained?

48
Collection of data using non-invasive procedures
routinely used in clinical practice
  • Subject selection, recruitment
  • If a medical device is used, has FDA approval
  • Identifiers, confidentiality measures

49
Research on individual or group characteristics
or behavior (ie, perception, cognition, language,
communication, cultural beliefs, social behavior)
  • Subject selection, recruitment procedures
  • Collection of identifiers vs. anonymous
  • Nature of the data collected
  • Confidentiality provisions
  • Compensation?

50
Clinical studies of drugs, medical devices,food
additives, cosmetics, electronic products also
require approval by the FDA
51
A medical device, per FDA, is
  • Any health care product intended for use in
    diagnosis, cure, treatment or prevention of
    disease in man or animals
  • Some examples surgical lasers, wheelchairs,
    sutures, pacemakers, vascular grafts, intraocular
    lenses, orthopedic pins
  • Also includes diagnostic aids such as reagents
    and test kits for in vitro diagnosis (IVD) of
    disease and other medical conditions

52
The Protection of Human Research Participants is
a Shared Responsibility
  • Research Team principal investigator,
    co-investigator, key personnel
  • Sponsor agency, or company
  • IRB chair, members, staff
  • Institution Institutional Official, leadership
  • Federal agencies - OHRP, FDA

53
NDSU IRB website
  • Basic information
  • Current protocol forms
  • Guidelines
  • Meeting schedule
  • Membership list
  • Links to online training, federal OHRP site,
    other information
  • www.ndsu.edu/irb
Write a Comment
User Comments (0)
About PowerShow.com